Lansforsakringar Fondforvaltning’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Lansforsakringar Fondforvaltning's BIIB Position: Q2 2026 in Review
Lansforsakringar Fondforvaltning reduced its Biogen (BIIB) stake by 3.2% in Q2 2026, selling an estimated $295K and leaving 46,265 shares worth $10M. The position accounts for 0.04% of the portfolio, ranked #300.
Lansforsakringar Fondforvaltning first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Lansforsakringar Fondforvaltning held 46,265 shares of Biogen worth $10M as of Q2 2026.
- Lansforsakringar Fondforvaltning sold 1,542 Biogen shares in Q2 2026, an estimated $295K.
- Biogen made up 0.04% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #300 holding.
- Lansforsakringar Fondforvaltning first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
- 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.